Non-Trauma Intervention to Treat PTSD for Veterans and Service Members Suffering From a TBI
T3 for PTSD
2 other identifiers
interventional
30
1 country
1
Brief Summary
The investigators want to test a treatment for posttraumatic stress disorder (PTSD) especially designed for military veterans and service members with mild or moderate traumatic brain injuries (TBI) and PTSD. The treatment will include individual psychotherapy sessions to manage PTSD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2026
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedStudy Start
First participant enrolled
March 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
March 9, 2026
January 1, 2026
12 months
January 9, 2026
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PTSD Checklist-DSM-5 (PCL-5)
The PCL-5 is a 20-item self-report measure designed to assess PTSD symptoms as defined by the DSM-5. The scoring involves summing the responses to 20 items (0 to 80) with higher scores indicating more severe PTSD.
Baseline to 6 months post treatment (approximately 8 months)
Secondary Outcomes (10)
Credibility and Expectancy Questionnaire
Baseline to 2 weeks post treatment (approximately 10 weeks)
Clinician Administered PTSD Scale for the Diagnostic and Statistical Manual of Mental Disorders Version 5 (DSM-5)
Baseline to 6 months post treatment (approximately 8 months)
Generalized Anxiety Disorder-7 (GAD-7)
Baseline to 6 months post treatment (approximately 8 months)
Patient Global Impressions (PGI) Scale
2 weeks post treatment to 6 months post treatment
Alcohol Use Disorders Identification Test (AUDIT)
Baseline to 6 months post treatment (approximately 8 months)
- +5 more secondary outcomes
Study Arms (1)
Active duty service members and veterans seeking clinical care for TBI
EXPERIMENTALMale and female active duty service members and veterans at least 18 years of age who are seeking clinical care for mild or moderate Traumatic Brain Injury (TBI) symptoms at the Intrepid Spirit Center located on Fort Hood who also have a co-occurring diagnosis of PTSD
Interventions
The treatment includes 8 sessions with each session lasting approximately 60 minutes. Sessions will cover relaxation training, identifying stress, stress management, and problem solving.
Eligibility Criteria
You may qualify if:
- Ability of participant to understand and the willingness to sign a written informed consent document based on interviewer assessment and clinical judgement.
- Any veteran or active duty service member (age 18 or above) diagnosed with mild or moderate TBI as determined by the Ohio State University Brain Injury Identification Method
- Participant meets diagnostic criteria for PTSD based on Clinician-Administered PTSD Scale (CAPS-5) interview as described by the National Center for PTSD which includes at least one Criterion B symptom, one Criterion C symptom, two Criterion D symptoms, and two Criterion E symptoms as well as meeting Criterions F and G.
- Ability to read, write, and speak English based on interviewer assessment and clinical judgement.
You may not qualify if:
- Participant is actively engaged in a behavioral intervention primarily targeting PTSD.
- Participant has a psychiatric problem that warrants immediate treatment as indicated in the electronic health record, flagged during testing, or confirmed by a clinician through screening or review of clinical notes.
- Participant demonstrates significant cognitive impairment that could impact treatment adherence/benefit based on interviewer assessment and clinical judgement.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Carl R Darnall Army Medical Center
Fort Hood, Texas, 76544, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cindy McGeary, PhD
The University of Texas Health Science Center at San Antonio
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 9, 2026
First Posted
January 20, 2026
Study Start
March 5, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
March 9, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Public data will be shared at the end of the study after the data is analyzed.
Individual Participant data may be shared with the research study team, the IRB, the Department of Defense representatives and state or Federal Government officials where required by law. Only deidentified data will be shared in a peer reviewed journal or in the summary results in ClinicalTrials.gov.